If you are here at two in the morning running through your symptoms, start with this: ovarian cancer is uncommon, and almost everything on your list has a benign explanation. What follows is not reassurance for its own sake — it is the actual checklist a specialist uses.
Almost certainly not — and that is a statement about probability, not a dismissal. Ovarian cancer is uncommon. The symptoms it causes are extremely common, and they are shared with irritable bowel syndrome, constipation, ovarian cysts, fibroids, urinary infection, endometriosis, perimenopause and ordinary dietary variation. For every woman whose bloating turns out to be ovarian cancer, a very large number have a benign explanation.
But almost certainly not is not the same as don't check, and this page exists because the old advice was worse. For decades ovarian cancer was called a silent killer, which taught women that there was nothing to notice and nothing to do. That turned out to be wrong. Most women diagnosed with ovarian cancer had symptoms for months beforehand. The symptoms were there. What was missing was a way to read them.
So the question worth asking is not do I have these symptoms? — most women do, at least sometimes. It is do I have this pattern? Four symptoms, new within the last year, present on more than 12 days a month. That is the checklist below, and working through it honestly will tell you whether to book an appointment or go back to sleep.
Ovarian cancer is far less common than the symptoms it causes. Having the symptoms is weak evidence; having the pattern is much stronger.
The majority of women report symptoms in the months before diagnosis. The problem was never the absence of warning — it was how to read it.
A clinical examination plus, where warranted, a pelvic ultrasound answers the question for most women in a single appointment.
The symptom index that underpins this page came from case-control research comparing women later diagnosed with ovarian cancer against women attending clinics without it. Only four symptoms discriminated between the groups: abdominal bloating, difficulty eating or feeling full quickly, pelvic or abdominal pain, and urinary urgency or frequency. The index performed best when those symptoms were new within the past year and occurred on more than 12 days a month — and it identified a meaningful proportion of women with early-stage disease, not only advanced disease. That finding is what retired the phrase “silent killer”. Source: Goff BA et al., Cancer (2007); NCCN Ovarian Cancer guidelines.
Answer each of these for the last month. You are not looking for a yes on any single line — you are looking at how many, how often, and how recently. Take a moment over the frequency questions; guessing at them is what makes this checklist useless.
Has your abdomen felt bloated, tight or swollen — not just after a heavy meal, but as a background state? Count the days in the last month, honestly. Does it settle overnight and after opening your bowels, or is it simply there? Bloating that fluctuates and has been part of your life for years is a very different answer from bloating that appeared three months ago and has not left. See persistent bloating.
Can you finish a meal you would have finished easily six months ago? Not whether you want to eat — whether you are physically able to. Many women have quietly reduced their portions without registering it as a change, so the useful test is comparison with the past rather than how today felt. See feeling full quickly.
A dull ache or a sense of pressure low in the abdomen or on one side, present on most days. Severity is not the question — persistence is. Pain that reliably tracks ovulation or your period is reassuring; pain that has lost any relationship to your cycle, or that has appeared after the menopause, is the version that counts. See pelvic pain.
Needing to pass urine more often or more urgently than you used to, without the burning of an infection and with urine tests that come back clear. Recurrent urinary symptoms with repeatedly negative cultures are the version worth mentioning. See urinary symptoms.
For each symptom you answered yes to: on how many days in the last month was it present? The threshold that research has repeatedly found meaningful is more than 12 days a month. If you genuinely cannot say, mark a calendar for the next two to three weeks — that alone is more useful than any amount of searching.
Is this new within the last year? A symptom you have lived with for a decade behaves differently from one that started in March. The index applies to symptoms present for less than a year, because a long-standing stable pattern points to a chronic benign cause rather than a growing one.
If one or more of the four symptoms is new, present on more than 12 days a month, and has lasted more than two to three weeks — book an appointment. That is the whole rule.
Half of the value of a checklist is knowing what to stop worrying about. These are the findings that most often send women to search at midnight and least often mean anything.
Bloating in the week before your period, one-sided pain mid-cycle that lasts a day or two, breast tenderness that comes and goes — these follow hormones. A symptom you can predict from a calendar is behaving like a hormonal symptom, not a growing mass. This is among the most reassuring patterns there is.
A decade of bloating that flares and settles, crampy pain that eases after opening your bowels, a lifelong sensitive stomach. The symptom index applies to symptoms new within the past year, because a stable long-standing pattern points to a chronic benign cause such as irritable bowel syndrome.
Bloating alone, on some days, with a normal appetite, no pain, no urinary change, a stable weight and an abdomen that looks as it always has. In the great majority of women eventually diagnosed, the symptoms travel together rather than alone.
This cuts both ways and deserves saying plainly: a normal CA-125 does not exclude ovarian cancer, and a raised one does not diagnose it. It rises in endometriosis, fibroids, pelvic infection, liver disease and even during a period. It is not a screening test, and it is not the answer to this question.
None of these means you have cancer. Each lowers the threshold for being examined rather than waiting another month to see what happens.
The benign hormonal explanations for bloating and pelvic pain no longer apply after the periods stop, so the same symptom carries more weight.
The symptoms travelling together is more meaningful than any one of them alone, and it is the combination the symptom index was built around.
A measurable change — waistbands that no longer fasten — rather than only a feeling of tightness. This warrants prompt imaging, particularly if you are eating less.
A first-degree relative with ovarian, breast, bowel or endometrial cancer changes your baseline risk. See BRCA and hereditary risk.
Losing weight without trying always warrants assessment, whatever the suspected cause and whatever else is or is not happening.
Bleeding after menopause needs a gynaecological assessment regardless of every other answer on this page.
And the exception to all of it: sudden severe one-sided pelvic pain, especially with vomiting, needs same-day assessment rather than a routine appointment.
A 45-minute appointment, a proper examination and — where it is warranted — an ultrasound. The great majority of women leave with a benign explanation and stop worrying.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. Searching cannot examine you or scan you — and those two things are what actually answer the question.
Knowing the shape of the appointment removes a good deal of the dread. For most women the whole process is one conversation, one examination and one scan.
Which symptoms, since when, how many days a month, whether they fluctuate, what makes them better or worse, what has happened to your weight and appetite, and your family history of ovarian, breast, bowel and endometrial cancer. This does more diagnostic work than any single test, which is why CION consultations run to 45 minutes rather than five.
The abdomen is examined for distension, a palpable mass and free fluid; a pelvic examination assesses the ovaries and uterus directly. It takes a few minutes. A normal examination is genuinely reassuring, though it does not stand alone against a concerning history.
A transvaginal scan gives a detailed view of both ovaries; a transabdominal scan assesses the wider abdomen and detects free fluid. Painless and radiation-free. For most women this is where the story ends — with a benign finding such as a functional cyst or a fibroid, or with nothing abnormal at all.
Where the pelvis is the concern, a CA-125 adds information when read together with the ultrasound and your age and menopausal status. It is not a screening test and never a standalone answer. More on how to read a CA-125.
If the ultrasound or CA-125 raises a genuine question, an MRI characterises an indeterminate ovarian mass, or a CT scan defines the extent of what is there. Neither is a routine next step after a normal ultrasound, and most women never reach this step.
Care moves to a gynaecologic-oncology pathway, starting with a tumour-board discussion of your case rather than a decision by one doctor. At CION, chemotherapy and maintenance treatment are delivered in-house across 35+ centres, with genetic counselling where it is warranted. Debulking and other gynaecologic-oncology surgery is coordinated with specialist partner centres and may be billed there.
For each of the four index symptoms, what usually turns out to be behind it. Ovarian cancer appears in every row — at the end of every row.
| Symptom | Much more often caused by | Also, less often |
|---|---|---|
| Persistent bloating | Irritable bowel syndrome, constipation, diet, hormonal cycling. | Ovarian cysts, fibroids, coeliac disease, ascites, ovarian cancer. |
| Feeling full quickly | Functional dyspepsia, gastritis, reflux, delayed gastric emptying, anxiety. | Enlarged liver or spleen, pelvic mass, ascites, ovarian cancer. |
| Pelvic or abdominal pain | Ovulation pain, period pain, IBS, urinary infection, endometriosis, fibroids. | Ovarian cyst rupture or torsion, pelvic inflammatory disease, ovarian cancer. |
| Urinary urgency or frequency | Urinary tract infection, overactive bladder, prolapse, diabetes, fibroid pressure. | Bladder pain syndrome, pelvic mass pressure, ovarian cancer. |
| All four together, most days, new | Still usually benign — but this is the pattern that earns a scan rather than reassurance. | The combination the symptom index was built to detect. |
*This table is a guide to likelihood, not a diagnosis. Only an examination and, where warranted, imaging can tell you which row you are actually in.
The worst version of this experience is a five-minute appointment that ends with a blood test and no explanation, leaving you to interpret a number on a report by searching for it. The second worst is being told not to worry without anyone actually examining you. Both are common, and both are why women end up here at two in the morning.
Your first consultation at CION is free and runs to about 45 minutes — long enough to take the history that this page has asked you to prepare. We do not order tests you do not need: a CA-125 in a 30-year-old with cyclical bloating and a normal examination answers nothing and worries everyone. Where the answer is that nothing is wrong, we say so plainly and explain why.
Where the assessment does find ovarian cancer, you are not starting from scratch. CION delivers medical oncology in-house — chemotherapy and maintenance therapy across 35+ centres in Telangana and Andhra Pradesh — alongside genetic counselling for women whose family history or diagnosis warrants it. Debulking and other gynaecologic-oncology surgery is coordinated with specialist partner centres and may be billed there. We would rather be straightforward about that now than have you discover it later.
Free and unhurried, with a specialist. Long enough to work through the checklist properly rather than tick one box.
Cases that raise a question are reviewed by a multidisciplinary group — medical oncology, imaging and pathology — not decided by one clinician alone.
Decisions for healing, not billing. Where the history and examination are reassuring, we say so instead of running a panel to look thorough.
Assessment, follow-up and any chemotherapy near where you live across Telangana and Andhra Pradesh, rather than repeat trips to one city hospital.
Four symptoms carry most of the signal: persistent abdominal bloating, feeling full quickly or difficulty eating, pelvic or lower abdominal pain, and urinary urgency or increased frequency. Each of these is far more often caused by something benign, which is why the pattern matters more than the presence of any one of them. The combination associated with ovarian cancer is symptoms that are new within the past year, present on more than 12 days in a month, and usually travelling together rather than alone. Fatigue, unintended weight loss and a change in bowel habit can accompany them but are less specific.
Three features separate them in most cases. Timeline: IBS is usually a long-standing pattern present for years, while the concerning pattern is new within the past year. Fluctuation: IBS symptoms flare and settle, and bloating typically eases after opening the bowels, whereas the concerning pattern is present on most days and does not settle. Company: IBS travels with a change in stool frequency or form, while the ovarian pattern travels with early satiety, urinary urgency or a genuinely enlarging abdomen. One important caveat — a new diagnosis of IBS in a woman over 50 is uncommon and warrants examination first.
Not for women at average risk. Large randomised trials of screening with CA-125 and transvaginal ultrasound in the general population have not shown a reduction in ovarian cancer deaths sufficient to justify routine screening, and screening carries real harms including unnecessary surgery for benign findings. This is why CA-125 should not be ordered as a general check. Women at high risk — for example those with a BRCA1 or BRCA2 pathogenic variant or a strong family history — are managed differently, through a genetics service that discusses surveillance and risk-reducing options individually.
No blood test can answer that on its own, and CA-125 in particular is widely misunderstood. It is a protein that can rise in ovarian cancer, but it also rises in endometriosis, fibroids, pelvic inflammatory disease, liver disease and even during a normal period, and it can be entirely normal in some early ovarian cancers. A normal result therefore does not exclude the disease and a raised result does not diagnose it. Where CA-125 genuinely adds information is alongside a pelvic ultrasound in a woman who has symptoms, interpreted together with her age and menopausal status.
No — but it does mean you should book an appointment rather than continue searching. Having all four symptoms is uncommon and it is the pattern the symptom index was designed to detect, so it warrants an examination and almost certainly a pelvic ultrasound. It remains true that most women with all four symptoms will turn out to have a benign explanation, and quite often more than one: constipation and a fibroid together, for example, can produce the whole picture. The point of getting checked is that a single appointment and one scan usually resolve it either way.
For persistent symptoms that fit the pattern — new, present on more than 12 days a month, lasting more than two to three weeks — a routine appointment booked now is appropriate; you do not need emergency care. Move faster if you are post-menopausal with new symptoms, if you are losing weight without trying, if your abdomen is visibly and progressively enlarging, or if you have bleeding after the menopause. The one genuine emergency is sudden severe one-sided pelvic pain, especially with vomiting, which needs same-day assessment because ovarian torsion is time-critical.
It happens, and it is worth knowing how to push back constructively. Bring specifics rather than impressions: which of the four symptoms, when each started, and how many days in the last month each was present — a calendar you have marked for two to three weeks is genuinely persuasive. Ask directly whether a pelvic examination and an ultrasound are warranted, and say if you have a family history of ovarian, breast, bowel or endometrial cancer. If you remain unsatisfied, a second opinion is reasonable and at CION the first consultation is free.
The first consultation is free and runs to about 45 minutes. CION delivers medical oncology for ovarian cancer in-house, covering chemotherapy and maintenance treatment across more than 35 centres in Telangana and Andhra Pradesh, alongside genetic counselling where family history or the diagnosis warrants it. Debulking surgery and other gynaecologic-oncology surgery is coordinated with specialist partner centres and may be billed there — we state that upfront rather than leaving it to be discovered later. Every case that raises a question is reviewed at a tumour board rather than decided by one doctor alone.